Scholarlink

Background <p>This study systematically analyzes the research landscape of lung cancer and pulmonary microbiota from 2015 to 2024 using bibliometric methods. </p> Methods <p>The Web of Science Core Collection provided data analyzed to uncover key contributors, pivotal research hotspots, and evolving trends.</p> Results <p>Results revealed a significant shift in focus from infections and inflammation to immunotherapy, microbial biomarkers, and immune response modulation, reflecting interplay between pulmonary microbiota and immune regulation in tumorigenesis. Major contributors, including China and the United States, along with leading journals, have driven progress in this interdisciplinary field, highlighting microbial imbalance's involvement in tumorigenesis and immune modulation. The findings underscore the potential of pulmonary microbiota as therapeutic targets and immune modulators, particularly for improving immunotherapy outcomes.</p> Conclusions <p>This study provides a comprehensive overview of the field, offering insights into its current status and future directions, and establishes a foundation for further exploration of personalized medicine and immune-centered therapies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Immunoregulatory role of pulmonary microbiota in lung cancer: a bibliometric analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年6月11日

查看全文
  • Huijun Jia,
  • Yifan Gong,
  • Hongyu Wei,
  • Chengguang Zhao,
  • Qiwei Zang,
  • Constance Sat Lin Liew

摘要

Background

This study systematically analyzes the research landscape of lung cancer and pulmonary microbiota from 2015 to 2024 using bibliometric methods.

Methods

The Web of Science Core Collection provided data analyzed to uncover key contributors, pivotal research hotspots, and evolving trends.

Results

Results revealed a significant shift in focus from infections and inflammation to immunotherapy, microbial biomarkers, and immune response modulation, reflecting interplay between pulmonary microbiota and immune regulation in tumorigenesis. Major contributors, including China and the United States, along with leading journals, have driven progress in this interdisciplinary field, highlighting microbial imbalance's involvement in tumorigenesis and immune modulation. The findings underscore the potential of pulmonary microbiota as therapeutic targets and immune modulators, particularly for improving immunotherapy outcomes.

Conclusions

This study provides a comprehensive overview of the field, offering insights into its current status and future directions, and establishes a foundation for further exploration of personalized medicine and immune-centered therapies.